info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » biotechnology

biotechnology

Cell Line Development Serum Market By Product Type (Fetal Bovine Serum, Human Serum, Animal-Free Alternatives); By Application (Biopharmaceutical Production, Stem Cell Research, Vaccine Development, Gene Therapy); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs/CDMOs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Line Development Serum Market will witness a robust CAGR of 8.1%, valued at USD 1.9 billion in 2024, expected to appreciate and reach nearly USD 3.0 billion b... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Vectorized Antibodies for In Vivo Expression Market By Delivery Vector (mRNA-based Vectors, AAV & Viral Vectors, DNA Plasmids & Synthetic Systems); By Therapeutic Application (Infectious Diseases, Oncology, Rare Genetic Disorders, Autoimmune Diseases); By End User (Biopharma Companies, Academic Research Centers, Public Health Agencies, Military Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vectorized Antibodies For In Vivo Expression Market is expected to grow at a robust CAGR of 11.7%, with a valuation of USD 3.2 billion in 2024, projected to reach ... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Viral Clearance Market By Product Type (Viral Filtration Systems, Chromatography-based Viral Clearance, Inactivation Agents); By Application (Gene Therapy, Biologics, Vaccines, Blood and Plasma Products); By End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Research and Academic Institutions, Blood and Plasma Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viral Clearance Market is poised for strong growth, registering a compound annual growth rate (CAGR) of approximately 8.5%. Valued at USD 1.8 billion in 2024, the market i... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Nanobodies Market By Application (Therapeutics, Diagnostics, Research Tools); By Therapeutic Area (Oncology, Autoimmune Diseases, Neurology, Infectious Diseases); By End User (Biopharma Companies, Academic Research Institutes, Diagnostic Labs, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nanobodies Market will witness a strong CAGR of 13.8%, valued at USD 1.4 billion in 2024 and expected to reach nearly USD 3.1 billion by 2030 , according ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Oligonucleotide Therapeutics Market By Drug Type (Antisense Oligonucleotides, Small Interfering RNAs, Aptamers, Others); By Application (Rare Genetic Disorders, Oncology, Metabolic/Liver Diseases, Infectious Diseases, Ophthalmology); By Route of Administration (Subcutaneous, Intrathecal, Intravenous, Others); By End User (Academic Hospitals, Specialty Clinics, Outpatient Centers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oligonucleotide Therapeutics Market is expected to witness a strong CAGR of 14.6%, valued at USD 8.1 billion in 2024 and projected to surpass USD 18.4 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Adipose-derived Stem Cell Market By Cell Type (Autologous, Allogenic); By Application (Regenerative Medicine, Aesthetic Medicine, Wound Healing & Tissue Repair, Drug Discovery & Research); By End User (Hospitals & Specialty Clinics, Cosmetic & Aesthetic Clinics, Research Institutions, Biotech & Cell Therapy Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adipose-Derived Stem Cell Market will witness a robust CAGR of 9.6%, valued at USD 1.6 billion in 2024 and expected to reach USD 2.8 billion by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Plant-based Vaccines Market By Vaccine Type (Prophylactic Vaccines, Therapeutic Vaccines); By Target Indication (Influenza, COVID-19, HPV, Zika Virus, Others); By Plant System (Tobacco, Maize, Potato, Tomato, Lettuce); By End User (Public Health Agencies, Hospitals & Clinics, Academic & Research Institutions, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plant-Based Vaccines Market is projected to expand at a robust pace between 2024 and 2030, with the market estimated at around USD 1.4 billion in 2024 and forecasted to re... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Gene Therapy in Ophthalmology Market By Therapy Type (Gene Augmentation, Gene Editing, RNA-based Therapy); By Disease Indication (Leber Congenital Amaurosis, Retinitis Pigmentosa, Stargardt Disease, Choroideremia, X-linked Retinoschisis, Wet AMD, Diabetic Macular Edema); By Delivery Method (Subretinal, Suprachoroidal, Intravitreal); By End User (Academic Medical Centers, Specialty Retina Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gene Therapy In Ophthalmology Market will witness a robust CAGR of 26.5% , valued at USD 1.42 billion in 2024 , and expe... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Continuous Bioprocessing Market By Product Type (Upstream Bioreactors, Continuous Chromatography, TFF Systems, PAT, Single-Use Systems, Automation Software); By Application (Clinical Production, Commercial Manufacturing, R&D, Process Development); By End User (Pharmaceutical Companies, Biotech Startups, CDMOs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Continuous Bioprocessing Market will witness a robust CAGR of 15.1%, valued at USD 4.3 billion in 2024, expected to appreciate and reach USD 10.2 billion by 2030,<... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Nucleic Acid Therapeutics Market By Therapy Type (Antisense Oligonucleotides, RNA Interference, mRNA Therapeutics, Aptamers, Others); By Application (Genetic Disorders, Oncology, Infectious Diseases, Neurological Disorders, Others); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nucleic Acid Therapeutics Market will witness a robust CAGR of 16.3%, valued at USD 6.8 billion in 2024 and expected to appreciate and reach USD 16.4 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Nano Biotechnology Market By Product Type (Nanoparticles and Nano-carriers, Nano-biosensors, Nano-imaging agents, Nanostructured scaffolds, Nano-based reagents); By Application (Drug Delivery, Diagnostics, Regenerative Medicine, Therapeutics, Agriculture, Food Safety); By End User (Hospitals and Clinics, Research Institutes and Universities, Biotechnology and Pharmaceutical Companies, Diagnostic Labs, Agriculture and Food Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nano Biotechnology Market is projected to grow at an CAGR of 12.3% from 2024 to 2030, with an estimated value of $48.7 billion in 2024 and a forecasted value of $9... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Nano Bioreactor Market By Product Type (Microfluidic Nano Bioreactors, Stirred Tank Nano Bioreactors, Perfusion-Based Nano Bioreactors, Batch and Fed-Batch Nano Bioreactors); By Application (Biopharmaceutical R&D, Cell Therapy, Synthetic Biology, Single-Cell Analysis, Academic Research); By End User (Biotech and Pharma Companies, CROs, Academic and Government Institutes, Diagnostic Startups); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nano Bioreactor Market is on track to grow at a CAGR of 13.9%, valued at approximately USD 620.4 million in 2024 and projected to reach nearly USD... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Virtual 3D Nanorobots Market By Application (Medical Research & Simulation, Nano-Drug Delivery, Nano-Surgical Training, Non-Medical Industrial Applications); By Component (Simulation Software Platforms, Visualization Interfaces, Predictive Modeling Tools); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Hospitals & Training Centers, Defense & Aerospace Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Virtual 3D Nanorobots Market is projected to expand at a rapid pace, moving from an estimated USD 1.8 billion in 2024 to approximately Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Nanoencapsulation Market By Material Type (Polymeric, Lipid-Based, Protein-Based); By Application (Pharmaceuticals, Functional Foods & Nutraceuticals, Cosmetics & Personal Care, Agrochemicals, Others); By End User (Pharmaceutical & Biotech Companies, Food & Beverage Manufacturers, Cosmetic Brands, Agrochemical Producers, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nanoencapsulation Market is set to expand at a CAGR of 11.6%, reaching a valuation of USD 7.9 billion in 2024, and projected to cross USD 15.3 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Muscarinic Acetylcholine Receptor Market By Product Type (Agonists, Antagonists, Allosteric Modulators); By Application (Neurology, Psychiatry, Respiratory, Ophthalmology, Cardiology); By Route of Administration (Oral, Inhalation, Topical/Ocular, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes, Community Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Muscarinic Acetylcholine Receptor (Machr) Market is set to grow at a CAGR of 6.8% , valued at USD 4.7 billion in 2024 and projected to re... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Artificial Womb Facility Market By Technology Type (Ex Vivo Biobag Systems, Integrated Artificial Placenta, Closed-Loop Monitoring Platforms, Others); By Application (Preterm Birth Support, Neonatal Disease Research, Fertility & Reproductive Medicine, Organ Maturation); By End User (Specialized Neonatal Hospitals, Research Institutes, Biotechnology Firms, IVF Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artificial Womb Facility Market will witness a remarkable CAGR of 24.6%, valued at USD 1.3 billion in 2024, and projected to grow to USD 4.9 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Antimicrobial Peptides Market By Product Type (Natural Peptides, Synthetic Peptides, Recombinant Peptides); By Application (Infectious Diseases, Dermatology, Oncology, Wound Healing, Others); By End User (Hospitals, Research Institutes, Pharmaceutical & Biotech Companies, Veterinary Clinics, Agricultural Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimicrobial Peptides Market is projected to grow at a CAGR of 8.1%, valued at around USD 1.65 billion in 2024 and expected to reach USD 2.8 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Lipid-Nanoparticle Based Genomic Medicines Market By Product Type (mRNA-Based Systems, siRNA-Based Systems, CRISPR and Gene-Editing Systems, DNA Plasmid-Based Systems); By Application (Oncology, Rare Genetic Disorders, Infectious Diseases, Regenerative Medicine); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic & Research Institutes, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lipid-Nanoparticle Based Genomic Medicines Market is projected to grow at a CAGR of 11.8%, valued at USD 6.9 billion in 2024 and expected to reach nearly USD 13.6 ... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Gut Microbiome Market By Product Type (Probiotics & Prebiotics, Microbiome Therapeutics, Diagnostics & Testing Kits); By Application (Digestive Health, Metabolic Disorders, Immunity & Inflammation, Mental Health, Oncology Support); By End User (Consumers, Hospitals & Clinics, Diagnostic Labs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gut Microbiome Market is poised to grow at a robust pace, reaching a value of $2.41 billion in 2024, and projected to cross $6.19 billion by 2030, expanding at a C... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Targeted Sequencing and Resequencing Market By Technology (Amplicon-Based, Hybridization-Based, CRISPR-Based); By Workflow Step (Sample Preparation, Library Preparation, Target Enrichment, Sequencing, Data Analysis); By Application (Oncology, Rare Disease, Pharmacogenomics, Reproductive Health); By End User (Clinical Laboratories, Academic & Research Institutions, Hospitals, Biopharma & CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Sequencing And Resequencing Market will witness a steady CAGR of 10.6%, valued at around USD 6.1 billion in 2024, expected to gr... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

CD Antigen Cancer Therapy Market By Antigen Target (CD19, CD20, CD22, CD33, CD47, CD123, Others); By Therapy Type (Monoclonal Antibodies, CAR-T Therapies, Bispecific Antibodies, Antibody-Drug Conjugates); By Cancer Type (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Academic Medical Centers, Specialty Cancer Hospitals, General Hospitals, Cell Therapy Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global CD Antigen Cancer Therapy Market will witness a strong CAGR of 16.2%, valued at USD 3.9 billion in 2024 and projected to reach USD 9.6 billion by ... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Immortalized Cell Line Market By Product Type (Human-Derived Cell Lines, Animal-Derived Cell Lines); By Application (Oncology, Virology, Immunology, Genetic Disorders, Stem Cell Research); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immortalized Cell Line Market will witness a CAGR of 9.1% , valued at USD 5.6 billion in 2024 , and projected to reach USD 9.4 billion by 2030 , according... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Biopharmaceutical Fermentation Market By Product Type (Microbial Fermentation, Mammalian Fermentation); By Application (Vaccines, Monoclonal Antibodies, Recombinant Proteins, Insulin and Hormones, Gene Therapy Vectors); By End User (Biopharmaceutical Companies, Contract Development & Manufacturing Organizations, Academic & Research Institutes, Government & Nonprofit Entities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biopharmaceutical Fermentation Market will witness a strong CAGR of 8.1% , valued at USD 29.7 billion in 2024 and expected to reach USD 47.5 billi... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Single Cell Multiomics Market By Technology Platform (Genomics, Transcriptomics, Epigenomics, Proteomics, Integrated Multiomics); By Application (Basic Research, Drug Discovery & Development, Clinical Diagnostics); By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Clinical Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Single Cell Multiomics Market is projected to grow at a robust CAGR of 14.5% , valued at an estimated USD 3.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Cardiac Tissue Engineering Market By Product Type (Cardiac Patches, Injectable Hydrogels, Bioprinted Tissues, Others); By Application (Ischemic Heart Disease, Heart Failure, Congenital Defects, Others); By End User (Academic and Research Institutes, Specialized Cardiac Centers, General Hospitals, Pharmaceutical and Biotech Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Tissue Engineering Market will grow at a CAGR of 11.8% , valued at around USD 1.3 billion in 2024 and projected to reach USD 2.8 billion b... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Mammalian Polyclonal IgG Antibody Market By Source (Rabbit, Goat, Horse, Sheep); By Application (Diagnostics, Research, Drug Discovery); By End User (Academic and Research Institutes, Biopharma Companies, Diagnostic Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mammalian Polyclonal IgG Antibody Market is set to grow at a CAGR of 8.1% , valued at USD 1.8 billion in 2024 , and projected to reach around USD ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

RNA Polymerase Market By Product Type (Bacterial RNA Polymerase, Phage RNA Polymerase, Eukaryotic RNA Polymerase); By Application (mRNA Therapeutics, Vaccine Manufacturing, Molecular Diagnostics, Synthetic Biology, Research); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RNA Polymerase Market will witness a steady CAGR of 6.8%, valued at $820 million in 2024, and is expected to reach nearly $1.22 b... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Stem Cell Exosome Therapeutics Market By Product Type (Natural Exosomes, Engineered Exosomes); By Application (Oncology, Neurology, Wound Healing & Dermatology, Inflammatory & Autoimmune Disorders); By Route of Administration (Injectable, Topical, Intranasal, Oral); By End User (Academic & Research Institutes, Biotech & Pharma Companies, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stem Cell Exosome Therapeutics Market is poised for accelerated growth, witnessing a projected CAGR of 27.5%, valued at USD 0.82 billion in 2024 and expec... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Molecular Glue Degrader Market By Target Protein (IKZF1/3, GSPT1, BCL6, STAT3, BRD9, Others); By Indication (Oncology, Neurology, Immunology, Others); By End User (Biopharma Companies, Academic Research Centers, CROs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Molecular Glue Degrader Market will witness a robust CAGR of 36.8%, valued at USD 413.0 million in 2024 , and expected to reach around Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Gene and Cell Therapies Targeting CNS Disorders Market By Therapy Type (Gene Therapy, Cell Therapy, Gene-Modified Cell Therapy); By Indication (Parkinson’s Disease, ALS, SMA, Huntington’s Disease, Alzheimer’s Disease, Rare Pediatric CNS Disorders); By Delivery Method (Intrathecal, Intravenous, Intraparenchymal, Intranasal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene and Cell Therapies Targeting CNS Disorders Market is set to grow at a compelling CAGR of 18.4% , starting from an e... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Cereblon E3 Ligase Modulators Market By Product Type (First-Generation IMiDs, Next-Generation Protein Degraders); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By End User (Hospital Oncology Departments, Specialty Cancer Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cereblon E3 Ligase Modulators Market will witness a robust CAGR of 12.5%, valued at an estimated USD 2.1 billion... Read More

Published Date: DEC-2025 | No Of Pages:183 | $ 4485

mRNA Cancer Vaccines Market By Cancer Type (Melanoma, Lung, Pancreatic, Colorectal, Breast, Prostate); By Vaccine Type (Personalized mRNA Vaccines, Off-the-Shelf Vaccines); By Delivery Mechanism (Lipid Nanoparticles, Polymer-Based Carriers, Exosomes); By End User (Academic & Research Institutes, Specialty Oncology Clinics, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Cancer Vaccines Market is projected to grow at a robust pace between 2024 and 2030, with an estimated value of USD 1.8 billion in 2024, expected to r... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

TROP2 Antibody Market By Drug Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Breast Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma, Others); By End User (Academic & Research Hospitals, Oncology Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TROP2 Antibody Market will witness a robust CAGR of 20.6%, valued at USD 1.8 billion in 2024, expected to appreciate and reach US... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

CD19 Antibody Market By Antibody Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates); By Application (Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Autoimmune Disorders, Others); By End User (Hospitals, Specialty Cancer Centers, Community Hospitals & Clinics, Outpatient Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD19 Antibody Market is set for considerable momentum, projected to grow at a compound annual growth rate (CAGR) of 14.8%, rising from an estimated USD 3.1 billion... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

CD276 Antibody Market By Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Oncology, Immuno-Oncology Research); By End User (Biopharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD276 Antibody Market is poised for significant momentum, with an estimated value of around USD 450 million in 2024 and an expected reach of USD 1... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Bicycle Toxin Conjugates Market By Product Type (Proprietary BTCs, Platform-Based BTCs, Next-Gen Conjugates); By Application (Oncology, Rare Diseases, Infectious Diseases); By End User (Academic Medical Centers, Cancer Institutes, Specialized Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bicycle Toxin Conjugates Market is projected to grow at a robust CAGR of 8.9%, with a market value estimated at $2.1 billion in 2024 and expected to reach $3.6 bil... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

CD137 Antibody Market By Type (Monoclonal Antibodies, Bispecific Antibodies, Fc-Engineered Variants); By Application (Solid Tumors, Hematologic Malignancies, Combination Immunotherapy); By Development Stage (Preclinical, Phase I, Phase II, Phase III); By End User (Academic Cancer Centers, Biopharma Companies, CROs, Specialty Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD137 Antibody Market is expected to grow steadily at a CAGR of 10.6%, valued at USD 782 million in 2024, and projected to reach around <... Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

CD3 Antibodies Market By Product Type (Monospecific CD3 Antibodies, Bispecific and Multispecific CD3 Antibodies); By Application (Oncology, Autoimmune Diseases, Transplantation, Others); By End User (Academic Hospitals, Specialty Clinics, Community Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD3 Antibodies Market is projected to register a strong Compound Annual Growth Rate (CAGR) of 10.8%, with an estimated value of $2.7 billion ... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Multispecific Antibodies Market By Technology Type (Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Formats); By Therapeutic Application (Oncology, Autoimmune & Inflammatory Disorders, Infectious Diseases, Others); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Multispecific Antibodies Market is gaining momentum, with the sector projected to expand steadily between 2024 and 2030. Based on inferred estimates, the market is valued ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Aryl Hydrocarbon Receptor Market By Drug Type (AhR Agonists, AhR Antagonists, Natural Ligands, Synthetic Ligands); By Therapeutic Application (Oncology, Autoimmune Disorders, Gastrointestinal Disease, Neuroinflammation, Dermatology); By Mechanism of Action (Direct Modulators, Indirect Modulators); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Aryl Hydrocarbon Receptor (Ahr) Market is projected to grow at a steady CAGR of 6.1%, estimated to reach approximately USD 738.4 million by 2030Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Medical Biomimetics Market By Product Type (Biomimetic Materials, Biomimetic Devices, Biomimetic Drug Delivery Systems); By Application (Cardiovascular, Orthopedic & Musculoskeletal, Ophthalmology, Dental, Others); By End User (Hospitals & Surgical Centers, Specialty Clinics, Academic & Research Institutes, Pharmaceutical & Biotech Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Medical Biomimetics Market is poised for considerable expansion, with an estimated value of $39.2 billion in 2024, forecasted to reach around $71.4 billion by 2030, growin... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Myc Proto Oncogene Protein Market By Product Type (Therapeutics, Diagnostics, Research Reagents); By Application (Oncology Therapeutics, Biomarker-Based Diagnostics, Research & Development); By End User (Hospitals & Cancer Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Myc Proto Oncogene Protein Market is anticipated to witness a robust CAGR of 8.5%, valued at around USD 4.2 billion in 2024, and is expected to reach USD 7.0 billi... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Ubiquitin Enzymes Market By Enzyme Class (E1 Activating Enzymes, E2 Conjugating Enzymes, E3 Ligases, Deubiquitinases); By Application (Drug Discovery & Development, Diagnostics & Biomarker Research, Basic Research, Therapeutics); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, CROs, Diagnostics & Clinical Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ubiquitin Enzymes Market is projected to expand steadily between 2024 and 2030, with an estimated value of USD 1.2 billion in 2024 and likely to reach USD 2.1 bill... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Live Cell Encapsulation Market By Polymer Type (Alginate-based, PEG-based, Synthetic, Natural Blends); By Cell Type (Islet Cells, Stem Cells, Immune Cells, Hepatocytes, Neural Cells); By Application (Therapeutics, Research Models, Biosensor Platforms); By End User (Academic & Research Institutes, Biotech Companies, Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Live Cell Encapsulation Market will witness a steady CAGR of 7.9%, valued at approximately USD 320.0 million in 2024, and expected to rea... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Buffer Preparation Market By Product Type (Automated Buffer Systems, Single-Use Buffer Systems, Manual & Semi-Automated Systems); By Application (Upstream Processing, Downstream Processing, Formulation & Fill-Finish); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Buffer Preparation Market is estimated at USD 4.8 billion in 2024 and is projected to reach USD 7.6 billion by 2030, expanding at a CAGR of 7.9%Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Next Generation Drug Conjugates Market By Product Type (Antibody-Drug Conjugates, Peptide-Drug Conjugates, Polymer-Drug Conjugates, Small Molecule-Drug Conjugates); By Payload Type (Cytotoxic Agents, Immune-Stimulatory Agents, RNA/siRNA Payloads, Antimicrobial Payloads); By Application (Oncology, Autoimmune Disorders, Infectious Diseases, Neurological Conditions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Next Generation Drug Conjugates Market is forecast to expand at a strong pace between 2024 and 2030, growing at a CAGR of 9.1%, moving from an estima... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Fc Fusion Protein Market By Therapeutic Area (Autoimmune Diseases, Oncology, Rare Diseases, Ophthalmology, Infectious Diseases); By Drug Type (Cytokine-Fc Fusions, Receptor-Fc Fusions, Enzyme-Fc Fusions, Hormone-Fc Fusions); By End User (Specialty Hospitals, Infusion Centers, Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fc Fusion Protein Market will witness a robust CAGR of 10.3%, valued at USD 5.6 billion in 2024 and expected to appreciate and reach Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Gene Switch Market By Switch Mechanism (Small-Molecule Inducible, Optogenetic, RNA-Based, CRISPR- and Protein-Based); By Application (Cell & Gene Therapy Safety, Synthetic Biology & Biomanufacturing, Agriculture & Plant Engineering, Basic Research Tools); By End User (Biopharmaceutical Companies, Academic & Research Institutes, Agri-Biotech Firms, Industrial Biotech & Manufacturing Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene Switch Market is estimated to be valued at USD 1.9 billion in 2024 and is projected to reach USD 5.6 billion by 2030 , growing at a CAGR of 19.8% ove... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

cGAS STING Pathway Market By Product Type (Agonists, Antagonists, Modulators); By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Rare Genetic Disorders); By End User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global cGAS STING Pathway Market is projected to see robust expansion through the decade, with an estimated CAGR of 22% , valued at USD ... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Immunocytokines Market By Product Type (Tumor-Targeted Immunocytokines, Anti-Inflammatory Immunocytokines, Next-Generation Modular Constructs); By Therapeutic Application (Oncology, Autoimmune & Inflammatory Disorders, Infectious Diseases); By Route of Administration (Intravenous, Subcutaneous, Targeted Delivery Platforms); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immunocytokines Market is projected to expand steadily between 2024 and 2030, with an inferred CAGR of 10.8% , reaching an estimated value of USD ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

RNA Extraction and RNA Purification Market By Product Type (RNA Extraction Kits, Reagents, Columns, Magnetic Beads, Instruments); By Technology (Silica Membrane-Based, Magnetic Bead-Based, Phenol-Chloroform); By End User (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Labs, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RNA Extraction and RNA Purification Market is projected to grow at a robust CAGR of 7.8% , valued at Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Cold Plasma Market By Application (Wound Healing, Surface Sterilization, Food Safety, Cancer Therapy, Surface Activation); By Industry (Healthcare, Electronics, Food Processing, Textiles, Aerospace); By Device Type (Atmospheric Pressure, Low-Pressure Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Plasma Market is projected to reach a value of $7.1 billion by 2030 , up from an estimated $3.9 billion in 2024 , registering a CAGR of 10.2%... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Research Antibodies and Reagents Market By Product Type (Primary Antibodies, Secondary Antibodies, ELISA Kits, Recombinant Proteins, Assay Kits, Custom Reagents); By Application (Research & Development, Diagnostics, Therapeutics, Personalized Medicine); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Clinical Diagnostics Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Research Antibodies and Reagents Market will witness a robust CAGR of 8.3%, valued at USD 13.5<... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Viral Vector Purification Market By Vector Type (Adenoviral, Lentiviral, AAV, Others); By Purification Method (Chromatography, Filtration, Centrifugation, Others); By End User (Biopharmaceutical Companies, CDMOs, Academic/Research Labs); By Application (Gene Therapy Manufacturing, Cell Therapy, Vaccine Production, Research); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Viral Vector Purification Market is projected to experience strong expansion, growing at a CAGR of 13.1% , valued at approximately USD 1.1 billion in 2024 and expected to ... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Microbial Fermentation CMO Market By Strain Type (Bacteria, Yeast, Fungi); By Service Type (Process Development, GMP Manufacturing, Analytical & Regulatory, Scale-Up & Tech Transfer); By Application (Biopharmaceuticals, Industrial Enzymes, Food & Ingredients, Cosmetics & Specialty Chemicals); By End User (Biopharma Companies, Industrial Firms, Synbio Startups, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microbial Fermentation CMO Market is projected to grow at a robust CAGR of 9.3% , reaching USD 5.2 billion in 2024 , and expected to exceed USD 8.... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Plant-Based Protein Expression Market By Expression System (Transient Expression, Stable Expression); By Application (Therapeutic Proteins, Vaccines, Industrial Enzymes, Nutraceuticals); By End User (Biopharmaceutical Companies, CDMOs, Academic Institutions, Agro-Biotech Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plant-Based Protein Expression Market will witness a strong CAGR of 9.8% from 2024 to 2030, valued at USD 1.6 billion in 2024 and projected to reach nearl... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Transfer Membrane Market By Product Type (Western Blot, Southern/Northern Blot, Dot/Slot Blot); By Material (Nitrocellulose, PVDF, Nylon); By Application (Protein Analysis, Nucleic Acid Detection, Diagnostics, Food & Environmental Testing); By End User (Academic Institutes, Pharma & Biotech, Clinical Labs, Food & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transfer Membrane Market is projected to expand at a steady pace, growing at a CAGR of 6.5% , valued at around USD 1.1 billion in 2024 and expected to rea... Read More

Published Date: DEC-2025 | No Of Pages:158 | $ 4485

DNA Vaccine Market By Type (Plasmid DNA Vaccines, Recombinant DNA Vaccines); By Application (Infectious Diseases, Oncology, Veterinary); By End User (Hospitals, Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Vaccine Market will witness a robust CAGR of 12.8%, valued at USD 4.3 billion in 2024 , expected to appreciate and reach USD ... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Automatic Aseptic Sampling Market By Product Type (Modular Sampling Systems, Single-Use Sampling Devices, Multi-Port Automated Stations); By Application (Biopharmaceuticals, Vaccines, Cell & Gene Therapy); By End User (Biopharma Manufacturers, CMOs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Automatic Aseptic Sampling Market is projected to grow at a CAGR of 10.3% , reaching an estimated USD 1.7 billion by 2030 , up from USD 850 million in 2024Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

mRNA Synthesis and Manufacturing Market By Workflow Stage (Upstream Template Synthesis, IVT Transcription, Downstream Purification & Capping, Formulation & Fill-Finish); By Application (Vaccines, Oncology, Gene Editing, Autoimmune & Rare Diseases); By End User (Biopharma Innovators, CDMOs, Academic Institutes, Government/Public Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Synthesis and Manufacturing Market is on track to expand at a CAGR of 11.8% , reaching approximately USD 14.6 billion by 2030 , up f... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Biopreservation Market By Product Type (Biopreservation Media, Equipment, LIMS, Accessories & Consumables); By Biospecimen Type (Stem Cells, Organs, DNA/RNA, Blood Samples, Human Tissues, Vaccines); By Application (Biobanking, Regenerative Medicine, Drug Discovery, Transplant Medicine); By End User (Pharmaceutical & Biotech Companies, Hospitals, Academic Institutes, Biobanks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biopreservation Market is projected to expand steadily, reaching around USD 5.8 billion in 2024 and forecasted to surpass USD 9.7 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Fc and Glycoengineered Antibodies Market By Antibody Type (Fc-engineered Antibodies, Glycoengineered Antibodies, Hybrid Variants); By Therapeutic Application (Oncology, Autoimmune Diseases, Infectious Diseases, Transplant Immunology); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes, CROs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fc and Glycoengineered Antibodies Market will witness a robust CAGR of 10.2%, valued at USD 4.7 billion in 2024 and expe... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

ADC Cytotoxic Payloads and Warheads Market By Payload Type (Microtubule Inhibitors, DNA-Damaging Agents, Topoisomerase Inhibitors, RNA Polymerase Inhibitors, Immune Payloads); By Linker Compatibility (Cleavable, Non-Cleavable, Site-Specific); By Therapeutic Application (Hematologic Cancers, Solid Tumors, Resistant/Refractory Cancers); By End User (Biopharma Companies, CDMOs, Research Institutes, IP Holding Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ADC Cytotoxic Payloads And Warheads Market is projected to grow at a robust CAGR of 14.7% , rising from an estimated Read More

Published Date: DEC-2025 | No Of Pages:151 | $ 4485

Bio Decontamination Market By Technology (Vaporized Hydrogen Peroxide [VHP] Systems, Ultraviolet [UV-C] Systems, Ozone-Based Systems, Other Chemical & Steam Solutions); By Application (Healthcare Facilities, Pharmaceutical & Biopharmaceutical Manufacturing, Laboratories & Research Institutes, Food & Beverage Industry); By End User (Hospitals & Clinics, Pharmaceutical Companies, Laboratories, Food Processing Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bio Decontamination Market is poised for substantial growth, with a projected CAGR of 9.4 % , estimated at USD 5.2 Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Nanotechnology Drug Delivery Market By Nanocarrier Type (Liposomes, Polymeric Nanoparticles, Solid Lipid Nanoparticles, Dendrimers, Nanoemulsions, Inorganic Nanoparticles); By Application (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases, Autoimmune Disorders, Ophthalmology); By Route of Administration (Intravenous, Oral, Topical, Pulmonary, Ocular, Transdermal); By End User (Hospitals, Specialty Clinics, Research Institutes, Pharmaceutical Companies, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nanotechnology Drug Delivery Market will witness a robust CAGR of 15.8%, valued at approximately USD 81.6 billion in 2024 and expected to surpass USD 197.4 billion... Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Large Molecule Drug Discovery Outsourcing Market By Service Type (Target Validation, Hit-to-Lead, Lead Optimization, Antibody Discovery, Bioanalytical Services); By Molecule Type (Monoclonal Antibodies, Recombinant Proteins, Peptides, Antibody-Drug Conjugates, RNA-based Molecules); By Therapeutic Area (Oncology, Autoimmune Disorders, Infectious Diseases, CNS Disorders, Rare Diseases); By End User (Emerging Biotech, Mid-Sized Pharma, Large Pharma, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Large Molecule Drug Discovery Outsourcing Market will witness a robust CAGR of 11.4%, valued at USD 5.8 billion in 2024 , expected to appreciate and reach USD 11.1... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Toxicity Testing Outsourcing Market By Testing Type (In Vivo, In Vitro, In Silico); By Application (Pharmaceuticals, Biotechnology, Chemicals, Cosmetics, Food); By End User (Pharmaceutical & Biotechnology Companies, Chemicals, Cosmetics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Toxicity Testing Outsourcing Market will expand at a robust CAGR of 8.1% , valued at USD 6.7 billion in 2024 , and projected to reach USD 10.8 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Protein Chip Market By Product Type (Analytical Protein Chips, Functional Protein Chips, Reverse-Phase Protein Chips); By Application (Drug Discovery & Development, Diagnostics, Proteomics Research, Others); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Protein Chip Market is projected to expand at a CAGR of 8.1% , reaching nearly USD 1.9 billion by 2030 , up from USD 1.1 billion in Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Unnatural Amino Acids Market By Product Type (α-Amino Acid Analogs, Non-Canonical Side Chain UAAs, Backbone-Modified UAAs); By Application (Pharmaceuticals & Biologics, Diagnostics & Imaging, Synthetic Biology & Protein Engineering, Advanced Materials & Industrial Use); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CDMOs, Industrial Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Unnatural Amino Acids Market is projected to expand at a steady pace between 2024 and 2030, with an inferred CAGR of 8.1% , moving from an estimated USD 1.4 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Micro Bioreactor System Market By Product Type (Standalone Systems, Modular/Integrated Systems); By Application (Cell Line Development, Process Optimization, Synthetic Biology, Personalized Therapy R&D); By End User (Biopharmaceutical & Biotechnology Companies, CDMOs, Academic & Research Institutions, Therapeutic Startups); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Micro Bioreactor System Market is projected to expand steadily between 2024 and 2030, with an CAGR of 9.1%, valued at roughly USD 1.7 billion in 2024 and ... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Base Editing Market By Product Type (Cytosine Base Editors, Adenine Base Editors, Dual-Function Editors); By Application (Genetic Disorders, Oncology, Cell Therapy Development, Drug Discovery); By End User (Academic and Research Institutions, Biotechnology and Pharmaceutical Companies, Hospitals and Clinical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Base Editing Market will witness a robust CAGR of 24.6%, valued at 640 million dollars in 2024 , expected to expand and reach 2.38 billion dollars by 2030... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Proteolysis Targeting Chimera (PROTAC) Market By Target Protein (Oncogenic, Inflammatory, Neurodegenerative); By Therapeutic Area (Oncology, Immunology, Neurology); By Delivery Mechanism (Oral, Parenteral); By End User (Biotech & Pharma Companies, Academic & Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Proteolysis Targeting Chimera (PROTAC) Market is on track to expand at a robust CAGR of 27.9% , climbin... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Cell Culture Incubator Market By Type (CO₂ Incubators, Multigas Incubators, Shaking/Hybrid Incubators); By Application (Pharmaceutical & Biotech R&D, Clinical Diagnostics, Stem Cell & Regenerative Medicine, Tissue Engineering & Biomanufacturing); By End User (Academic & Research Institutes, Pharma & Biotech Companies, CROs/CDMOs, Hospitals & Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Culture Incubator Market will witnes s a steady CAGR of 6.8% , valued at nearly USD 2.2 billion in 2024 and projected to reach USD 3.3 billio... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Recombinant Human Endostatin Market By Formulation (Injectable, Nano-formulated Endostatin); By Indication (Non-Small Cell Lung Cancer, Glioblastoma and Brain Tumors, Colorectal Cancer, Others); By Distribution Channel (Hospital Pharmacies, Specialty Cancer Clinics, Online/Institutional Procurement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Recombinant Human Endostatin Market is projected to expand at a robust CAGR of 8.6% , climbing from an estimated USD 678.3 million in 2024 to around USD 1.12 billi... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Purified Membrane Protein Market By Protein Type (GPCRs, Ion Channels, Transporters, RTKs, Others); By Expression System (Mammalian, Insect, Bacterial, Cell-Free); By Application (Drug Screening, Structural Biology, Antibody Discovery, Vaccine Design, Biophysical Assays); By End User (Biopharma Companies, Academic Institutions, CROs, CDMOs, AI Drug Discovery Firms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Purified Membrane Protein Market is expected to register a robust CAGR of 10.1% , reaching approximately USD 3.2 billion by 2030 , up from an estimated USD 1.8 bil... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Rabies Monoclonal Antibody Market By Product Type (Single Monoclonal Antibody, Combination Monoclonal Antibodies); By Route of Administration (Infiltration at Wound Site, Intramuscular Injection, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Government & NGO Supply Chains, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rabies Monoclonal Antibody Market is projected to grow at a robust CAGR of 8.7% , reaching a market value of approximately USD 710.2 million in 2024 , wit... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Biotech Ingredients Market By Type (Active Pharmaceutical Ingredients, Specialty Ingredients); By Application (Pharmaceuticals, Cosmetics & Personal Care, Food & Beverages, Agriculture & Animal Nutrition); By Production Method (Fermentation, Cell Culture, Enzymatic Synthesis); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biotech Ingredients Market will witness a robust CAGR of 9.45 % , valued at $52.8 billion in 2024 , expected to appreciate and reach Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Single-Cell Omics Market By Product Type (Single-Cell Sequencing, Consumables, Software); By Application (Cancer Research, Immunology, Neurology, Drug Discovery); By End User (Biotechnology & Pharmaceutical Companies, Academic Research Institutions, Clinical & Diagnostic Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Single-Cell Omics Market is on track for significant growth, with a projected CAGR of 22.4% from 2024 to 2030, moving from an estimated USD 10.1 billion <... Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Difficult to Express Protein Market By Product Type (Expression Systems, Reagents, and Consumables); By Application (Pharmaceutical & Biotechnology, Research & Development, Diagnostics); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, CROs, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Difficult To Express Protein Market is poised for significant growth between 2024 and 2030. Valued at USD 1.7 billion in 2024, the market... Read More

Published Date: NOV-2025 | No Of Pages:165 | $ 4485

Viral Sensitizers Market By Product Type (Synthetic Sensitizers, Natural Sensitizers); By Application (HIV/AIDS, Hepatitis, COVID-19, Influenza, Other Viral Infections); By End-User (Pharmaceutical & Biotech Companies, Hospitals & Clinics, Contract Research Organizations, Research & Academic Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viral Sensitizers Market will experience notable growth from 2024 to 2030, with a compound annual growth rate (CAGR) of 8.4% , valued at USD 4.7 billion in 2024Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Automated Cell Culture Systems Market By Product Type (Automated Systems, Consumables); By Application (Biopharmaceutical Manufacturing, Cell-Based Research, Regenerative Medicine); By End User (Biotech and Pharmaceutical Companies, Academic and Research Institutions, CROs, Biomanufacturers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Automated Cell Culture Systems Market is projected to experience a robust growth trajectory from 2024 to 2030. Valued at USD 3.5 billion in 2024, it is expected to reach <... Read More

Published Date: NOV-2025 | No Of Pages:194 | $ 4485

Polylysine Market By Application (Food Preservation, Cosmetics & Personal Care, Pharmaceuticals, Agriculture); By End User (Food and Beverage Industry, Cosmetics, Pharmaceuticals, Agriculture); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Polylysine Market is poised for strong growth, with a projected compound annual growth rate (CAGR) of 6.2% , valued at USD 1.2 billion in 2024, and is expected t... Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Insect Cell Lines Market by Product Type (Cell Lines, Culture Media & Reagents, Equipment & Systems); By Application (Biopharmaceuticals, Vaccine Production, Gene Therapy, Academic Research); By End User (Pharmaceutical & Biotech Companies, CROs, Academic & Research Institutes, Forensic & Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Insect Cell Lines Market is projected to experience steady growth from 2024 to 2030 , with an expected CAGR of 8.1% . Valued at USD 850 million in... Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

Mammalian Cell Fermentation Technology Market By Product Type (Bioreactors, Cell Culture Media, Consumables); By Application (Biopharmaceutical Manufacturing, Cell and Gene Therapy, Research and Development); By End User (Pharmaceutical & Biotech Companies, CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mammalian Cell Fermentation Technology Market is poised for significant growth, with a forecasted CAGR of 7.4%, valued at USD 5.3 billion in 2024, and expected to reach Read More

Published Date: NOV-2025 | No Of Pages:169 | $ 4485

Tissue-Engineered Skin Substitutes Market By Product Type (Biological Skin Substitutes, Synthetic Skin Substitutes); By Application (Burns, Chronic Wounds, Surgical Wounds, Cosmetic & Aesthetic Procedures); By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutions, Cosmetic & Aesthetic Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tissue-Engineered Skin Substitutes Market is poised for substantial growth, valued at USD 1.84 billion in 2024 with CAGR of 7.8% , reaching USD 2.... Read More

Published Date: NOV-2025 | No Of Pages:150 | $ 4485

3D Bioprinted Human Tissue Market by Application (Drug Development & Testing, Regenerative Medicine, Cosmetic Testing); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Contract Research Organizations, Healthcare Providers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global 3D Bioprinted Human Tissue Market is set to experience steady growth from 2024 to 2030, valued at approximately USD 1.5 billion in 2024, reaching nearly USD 8.5 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

Surface Plasmon Resonance (SPR) System Market By Product Type (Instruments, Consumables); By Application (Pharmaceutical & Biotechnology Analysis, Genomics & DNA Sequencing, Food & Environmental Testing, Academic & Research); By End-User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Contract Research Organizations, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Surface Plasmon Resonance ( SPR ) System Market is expected to grow at a robust CAGR of 7.67Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Bioprocess Validation Market By Process Type (Upstream, Downstream, PAT Validation); By Service Type (Consultation, Testing & Qualification, Documentation & Compliance); By End-User (Pharmaceutical & Biotech Companies, Contract Manufacturing Organizations, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bioprocess Validation Market is projected to grow at a robust CAGR of 7.5% , valued at USD 4.6 billion in 2024, and is expected to expand to USDRead More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Metagenomic Sequencing Market by Technology (Next-Generation Sequencing, Third-Generation Sequencing); By Application (Healthcare & Clinical Diagnostics, Environmental Monitoring, Agriculture & Food Safety, Research Institutions); By End User (Hospitals & Diagnostic Labs, Academic & Research Institutes, Contract Research Organizations, Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metagenomic Sequencing Market will witness a strong growth trajectory, with a projected CAGR of 16.5% from 2024 to 2030, expected to rise from USD... Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

DNA Polymerase Market By Product Type (Recombinant DNA Polymerase, Heat-Stable DNA Polymerase, Reverse Transcriptase Polymerase); By Application (PCR, NGS, Genetic Research, Forensic Testing); By End User (Biotech & Pharmaceutical Companies, Academic & Research Institutes, Clinical Diagnostic Labs, Forensic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Polymerase Market is poised for significant growth over the next few years. This enzyme plays a crucial role in DNA replication and amplification, making it indispensa... Read More

Published Date: NOV-2025 | No Of Pages:153 | $ 4485

Gene Synthesis Market By Product Type (Custom Gene Synthesis, Gene Libraries, Plasmids and Clones); By Application (Pharmaceutical & Healthcare, Agriculture & Food, Industrial Biotechnology, Environmental Biotechnology); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Contract Research Organizations, Agricultural & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene Synthesis Market is poised for significant growth, with an expected CAGR of 14.5% from 2024 to 2030, reaching a market value of USD 3.8 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:172 | $ 4485

Single Nucleotide Polymorphism (SNP) Genotyping Market By Product Type (Instruments, Consumables); By Technology (PCR, NGS); By Application (Pharmaceutical & Biotechnology, Diagnostics, Agriculture); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Clinical Laboratories, Agricultural Research); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Single Nucleotide Polymorphism ( SNP ) Genotyping Market is poised for notable growth, with a CAGR of 7.2%Read More

Published Date: NOV-2025 | No Of Pages:163 | $ 4485

RNA Analysis Market By Product Type (RNA Sequencing Platforms, Reagents, Consumables, Bioinformatics Tools); By Application (Genomics Research, Clinical Diagnostics, Therapeutic Development); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Contract Research Organizations, Healthcare Providers); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global RNA Analysis Market is poised for substantial growth, with a projected CAGR of 9.3% , valued at USD 8.5 billion in 2024. The market is ex... Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

Single Domain Antibody Platform Market By Product Type (Therapeutic Antibodies, Diagnostic Antibodies, Research Antibodies); By Application (Oncology, Infectious Diseases, Immunology, Others); By End User (Pharmaceutical and Biotech Companies, Academic and Research Institutions, Contract Research Organizations, Diagnostic and Clinical Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Single Domain Antibody Platform Market is poised for substantial growth, expected to experience a CAGR of 10.5% from 2024 to 2030 . Valued at around USD 1.5 billi... Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Protein Crystallization Market By Product Type (Crystallization Systems, Reagents & Consumables); By Application (Biopharmaceutical & Drug Discovery, Academic & Research Institutions, Agriculture & Environmental Sciences); By End User (Biopharmaceutical & Biotech Companies, Research Institutions, CROs, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Protein Crystallization Market will witness a steady growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 6.1% , valued at USD Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Antibody Discovery Market By Technology (Phage Display, Next-Generation Sequencing, Hybridoma Technology, Transgenic Animals); By Application (Cancer Immunotherapy, Autoimmune Diseases, Infectious Diseases, Others); By End User (Pharmaceutical & Biotech Companies, Contract Research Organizations, Academic & Research Institutions, Diagnostic & Clinical Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antibody Discovery Market is poised for robust growth, expected to be valued at USD 4.1 billion in 2024 with a CAGR of 8.21 %, ... Read More

Published Date: NOV-2025 | No Of Pages:167 | $ 4485

Mitochondrial DNA Market By Product Type (Testing Kits, Instruments); By Application (Genetic Testing, Research & Drug Development, Clinical Diagnostics); By End User (Hospitals & Diagnostic Labs, Research Institutions, Biotech & Pharmaceutical Companies, Genetic Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitochondrial DNA Market is projected to experience a solid growth trajectory from USD 1.2 billion in 2024 to nearly USD 2.3 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Strand Displacement Amplification (SDA) Market By Product Type (Instruments, Consumables); By Application (Infectious Disease Diagnostics, Genetic Testing, Forensic & Environmental Testing, Academic Research); By End User (Healthcare Providers, Research Institutions, Pharmaceutical & Biotech Companies, Contract Research Organizations, Forensic & Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Strand Displacement Amplification (SDA) market is on an upward trajectory, with a projected CAGR of 10.8% , expected to grow from USD 400 million in 2024 to USD 720 milli... Read More

Published Date: NOV-2025 | No Of Pages:163 | $ 4485

Cell Line Development Market by Product Type (Cell Lines, Reagents & Media, Instruments); By Application (Monoclonal Antibody Production, Gene Therapy, Vaccine Production, Cell-Based Research); By End User (Biopharmaceutical Companies, CDMOs, Academic & Research Institutes, Forensic & Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Line Development Market will witness a substantial growth trajectory, with a CAGR of 8.5%, valued at USD 5.1 billion in 2024, and expected to appreci... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Whole Genome Amplification (WGA) Market By Product Type (Instruments, Reagents, Services); By Application (Clinical Diagnostics, Genomics Research, Forensic Science, Personalized Medicine); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Contract Research Organizations, Hospitals & Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Whole Genome Amplification ( WGA ) Market is set to experience significant growth in the coming years. Valued at Read More

Published Date: NOV-2025 | No Of Pages:167 | $ 4485